AdvanSix Inc. Common Stock (ASIX)

FairStock Score: 47/100 — MIXED

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

As a value investor, I start with the business. AdvanSix makes nylon 6, caprolactam, ammonium sulfate, and acetone—useful industrial chemicals, but largely commodity products tied to the economic cycle. The Lynch category is cyclical chemicals, and that fits. Filed results show fiscal year 2025, the period ended 2025-12-31, net income was $49.3M and diluted EPS was $1.80; fiscal year 2024, the period ended 2024-12-31, net income was $44.1M and diluted EPS was $1.62; fiscal year 2023, the period ended 2023-12-31, net income was $54.6M and diluted EPS was $1.95. Then fiscal Q1 2026, the quarter ended 2026-03-31, produced a net loss of $15.5M and diluted EPS of -$0.58, while fiscal Q2 2026, the quarter ended 2026-06-30, had net income of only $3.2M and diluted EPS of $0.12. Fiscal year 2025, the period ended 2025-12-31, revenue was $1.5B; fiscal Q2 2026, the quarter ended 2026-06-30, revenue was $421.3M versus fiscal Q2 2025, the quarter ended 2025-06-30, revenue of $410.0M. On valuation, at the 2026-10-13 close of $16.63, FairStock shows P/B 0.56 and a negative P/E of -24.82. A sub-book price can be attractive for an asset-heavy chemical firm, but it also reflects poor returns: ROE -2.19%, ROCE 0.50%, and free cash flow -$25.8M, or -5.7% FCF yield. The 3.95% dividend and D/E 0.53 require watching because free cash flow is negative. Financial health is mixed: Piotroski 7/9 is encouraging, but Altman Z 1.18 is weak. Quality and moat? Limited. Integration helps, but competitors can add capacity, and end markets are cyclical. FairStock score 47/100 and EV/EBITDA 11.96 do not scream bargain despite the 0.56 P/B. This is a cyclical asset play—not a wonderful business at a fair price, but perhaps a fair asset at a cheap-looking price. I would need evidence that earnings normalize and cash flow turns positive before calling it compelling.

In plain English: AdvanSix makes industrial chemicals such as nylon 6, fertilizers, and acetone. Sales have stayed near $1.5 billion a year, but profits have been weak lately: a loss in the first quarter of 2026 and only a small profit in the second quarter. The stock price is below the company's accounting value, which can look cheap, but the business is using more cash than it brings in and earns low returns, so it looks like a risky, economy-sensitive value case rather than an obvious bargain.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data as of 2026-10-13 close · note generated 2026-10-15 · model deepseek-flash

Sources (SEC EDGAR): fiscal Q2 2026 10-Q (period ended 2026-06-30) · fiscal Q1 2026 10-Q (period ended 2026-03-31) · fiscal Q3 2025 10-Q (period ended 2025-09-30) · fiscal Q2 2025 10-Q (period ended 2025-06-30) · FY2025 10-K (period ended 2025-12-31) · FY2024 10-K (period ended 2024-12-31) · FY2023 10-K (period ended 2023-12-31)

Fundamentals from company filings and market-data providers; prices are end-of-day, not real-time. AI-generated analysis is general and educational — not personal investment advice. Scoring methodology · Score test · Disclaimer